These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24034056)

  • 21. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperuricemia and acute kidney injury following kidney transplantation : a case report].
    Nakazawa S; Imamura R; Yamamoto Y; Hayashi T; Tanigawa G; Fujita K; Hosomi M; Yamaguchi S
    Hinyokika Kiyo; 2013 Feb; 59(2):103-6. PubMed ID: 23552752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppression.
    Tojimbara T; Nakajima I; Sato S; Nakamura M; Kawase T; Kai K; Tsuda S; Kudo S; Fuchinoue S; Teraoka S
    Transplant Proc; 2004 Sep; 36(7):2087-9. PubMed ID: 15518755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful kidney transplantation from a cadaveric donor unsuitable for other centers due to acute renal failure: a case report.
    Bilgic A; Erdogan B; Kali A; Buyukbakkal M; Eser B; Bozkurt B; Kilic M; Ayli MD
    Transplant Proc; 2012; 44(6):1764-6. PubMed ID: 22841267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan.
    Nishimura K; Uchida K; Yuzawa K; Fukuda Y; Ichikawa Y; Akioka K; Fujisawa M; Sugitani A; Ito S; Nakatani T; Horimi T; Yoshimura N
    Transplant Proc; 2012 Jan; 44(1):147-9. PubMed ID: 22310601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil.
    Kabei K; Uchida J; Iwai T; Yamasaki T; Kuwabara N; Naganuma T; Kumada N; Nakatani T
    Transpl Immunol; 2014 Aug; 31(2):92-7. PubMed ID: 24932811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First successful perinatal management of pregnancy after ABO-incompatible liver transplantation.
    Higashi H; Obara H; Miyakoshi K; Shinoda M; Kitago M; Shimojima N; Abe Y; Hibi T; Yagi H; Matsubara K; Yamada Y; Itano O; Hoshino K; Kuroda T; Kitagawa Y
    World J Gastroenterol; 2017 Jan; 23(3):547-550. PubMed ID: 28210092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of cyclosporine and tacrolimus therapy with steroid withdrawal in living-donor renal transplantation: 5-year follow-up.
    Lee YJ; Kim B; Lee JE; Kim YG; Kim DJ; Kim SJ; Joh JW; Oh HY; Huh W
    Transpl Int; 2010 Feb; 23(2):147-54. PubMed ID: 19744223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABO-incompatible kidney transplantation.
    Schousboe K; Titlestad K; Baudier F; Hansen LU; Bistrup C
    Dan Med Bull; 2010 Oct; 57(10):A4197. PubMed ID: 21040684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with laparoscopic splenectomy for ABO-incompatible living renal transplantation without plasmapheresis.
    Hayashi T; Tahara H; Hara Y; Ishii T; Uemura H
    Transplant Proc; 2006 Sep; 38(7):1985-6. PubMed ID: 16979973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose versus high-dose cyclosporine induction protocols in renal transplantation.
    Ghafari A; Makhdoomi K; Ahmadpour P; Afshari AT; Fallah MM; Rad PS
    Transplant Proc; 2007 May; 39(4):1219-22. PubMed ID: 17524937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel approach to successful ABO-incompatible high-titer renal transplantation.
    Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T
    Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].
    Oppenheimer F; Revuelta I; Serra N; Lozano M; Gutiérrez-Dalmau A; Esforzado N; Cofán F; Ricart MJ; Torregrosa JV; Crespo M; Paredes D; Martorell J; Alcáraz A; Campistol JM
    Nefrologia; 2010; 30(1):54-63. PubMed ID: 20038970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol.
    Ando T; Tojimbara T; Sato S; Nakamura M; Kawase T; Kai K; Nakajima I; Fuchinoue S; Teraoka S
    Transplant Proc; 2004 Sep; 36(7):2182-3. PubMed ID: 15518793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.